110
Participants
Start Date
November 30, 2006
Primary Completion Date
December 31, 2008
Study Completion Date
May 31, 2009
SB-509
60 mg dose
Normal Saline
Peripheral Neuropathy Center, Weill Medical College of Cornell University, New York
Upstate Clinical Research, Albany
Altoona Center for Clinical Research, Duncansville
University of Miami, Diabetes Research Institute, Miami
Neurology Clinical Research, Sunrise
Bradenton Research Center, Bradenton
University of Kansas Medical Center, Kansas City
Creighton Diabetes Center, Omaha
Nerve and Muscle Center of Texas, Houston
DGD Research, San Antonio
Advanced Medical Research, LLC, Lakewood
Coordinated Clinical Research, La Jolla
SF Clinical Research Center, San Francisco
Diablo Clinical Research, Walnut Creek
Instituto Mexicano de Investigación Clinica, Mexico City
Lead Sponsor
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
Sangamo Therapeutics
INDUSTRY